galantamine has been researched along with Nerve Degeneration in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Akdağ, R; Alagöz, F; Aydın, S; Billur, D; Daglıoğlu, E; Karakoyun, DO; Şahinoğlu, M | 1 |
| Chu, K; Im, WS; Kim, M; Lee, ST; Park, JE | 1 |
| Agostinho, P; Garção, P; Melo, JB; Oliveira, CR; Sousa, C | 1 |
| Akkerman, M; Albuquerque, EX; Alkondon, M; Aracava, Y; Merchenthaler, I; Pereira, EF | 1 |
| Fang, J; Li, Q; Wu, D; Yang, M; Zhang, L; Zhang, Y | 1 |
| Capsoni, S; Cattaneo, A; Giannotta, S | 1 |
| Cremers, TI; Czollner, K; Harkany, T; Keijser, JN; Luiten, PG; Mulder, J; Nyakas, C | 1 |
| Capsoni, S; Cattaneo, A; Domenici, L; Origlia, N | 1 |
8 other study(ies) available for galantamine and Nerve Degeneration
| Article | Year |
|---|---|
Influence of galantamine on peripheral nerve degeneration after experimental compression injury of the rat sciatic nerve.
Topics: Animals; Crush Injuries; Galantamine; Male; Nerve Degeneration; Nerve Tissue; Peripheral Nerve Injuries; Rats; Rats, Wistar; Sciatic Nerve | 2022 |
Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease.
Topics: Analysis of Variance; Animals; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Galantamine; Huntington Disease; In Situ Nick-End Labeling; Male; Nerve Degeneration; Neurologic Examination; Nitro Compounds; Nootropic Agents; Propionates; Rats; Rats, Inbred Lew; Statistics, Nonparametric | 2008 |
Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cells, Cultured; Cerebral Cortex; Cholinesterase Inhibitors; Cytoprotection; Dose-Response Relationship, Drug; Galantamine; Glutathione; Lipid Peroxidation; Nerve Degeneration; Neurons; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Plaque, Amyloid; Rats | 2009 |
Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning.
Topics: Acetylcholinesterase; Animals; Atropine; Brain; Chemical Warfare Agents; Cholinergic Fibers; Cholinesterase Inhibitors; Cholinesterase Reactivators; Drug Interactions; Female; Galantamine; Guinea Pigs; Lethal Dose 50; Male; Muscarinic Antagonists; Nerve Degeneration; Organ Culture Techniques; Organophosphate Poisoning; Organophosphorus Compounds; Sarin; Soman; Treatment Outcome | 2010 |
Galantamine inhibits calpain-calcineurin signaling activated by beta-amyloid in human neuroblastoma SH-SY5Y cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Calcineurin; Calcineurin Inhibitors; Calpain; Cell Line, Tumor; Cholinesterase Inhibitors; Galantamine; Humans; Nerve Degeneration; Neuroblastoma; Peptide Fragments; Signal Transduction | 2010 |
Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antibodies; Choline O-Acetyltransferase; Cholinergic Agonists; Disease Models, Animal; Entorhinal Cortex; Galantamine; Humans; Mice; Mice, Knockout; Mice, Transgenic; Nerve Degeneration; Nerve Growth Factor; Phenotype; Phosphorylation; Recombinant Proteins; tau Proteins | 2002 |
Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Behavior, Animal; Choline O-Acetyltransferase; Cholinergic Fibers; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Galantamine; Hippocampus; Male; Maze Learning; Models, Animal; N-Methylaspartate; Nerve Degeneration; Neural Pathways; Neurotoxins; Nicotinic Antagonists; Rats; Rats, Wistar; Receptors, Nicotinic; Septal Nuclei; Space Perception | 2005 |
Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice.
Topics: Acetylcholine; Animals; Cholinergic Agonists; Galantamine; Long-Term Potentiation; Mice; Mice, Transgenic; Nerve Degeneration; Nerve Growth Factor; Neuronal Plasticity; Time Factors | 2006 |